OXFORD BIODYNAMICS LIMITED

OX1 3HA (South East)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£849,632

Mar 15 - Dec 17

Development of prognostic epigenetic biomarkers for ALS.

Innovate UK award to OXFORD BIODYNAMICS LIMITED and Julia Sherriff

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}